大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/22 | 4,092 | 4,095 | 4,030 | 4,036 | -102 | -2.5% | 769,500 |
2020/10/21 | 4,131 | 4,162 | 4,120 | 4,138 | +29 | +0.7% | 507,900 |
2020/10/20 | 4,111 | 4,150 | 4,099 | 4,109 | -24 | -0.6% | 642,600 |
2020/10/19 | 4,079 | 4,150 | 4,077 | 4,133 | +90 | +2.2% | 538,500 |
2020/10/16 | 4,044 | 4,062 | 4,021 | 4,043 | -35 | -0.9% | 737,100 |
2020/10/15 | 4,152 | 4,169 | 4,072 | 4,078 | -108 | -2.6% | 894,600 |
2020/10/14 | 4,177 | 4,194 | 4,151 | 4,186 | -9 | -0.2% | 694,100 |
2020/10/13 | 4,220 | 4,223 | 4,166 | 4,195 | -39 | -0.9% | 601,000 |
2020/10/12 | 4,228 | 4,265 | 4,209 | 4,234 | +4 | +0.1% | 623,400 |
2020/10/09 | 4,319 | 4,319 | 4,221 | 4,230 | -89 | -2.1% | 990,300 |
2020/10/08 | 4,343 | 4,353 | 4,317 | 4,319 | +12 | +0.3% | 689,100 |
2020/10/07 | 4,312 | 4,334 | 4,287 | 4,307 | -54 | -1.2% | 732,700 |
2020/10/06 | 4,331 | 4,366 | 4,318 | 4,361 | +44 | +1% | 420,600 |
2020/10/05 | 4,312 | 4,395 | 4,294 | 4,317 | +32 | +0.7% | 756,000 |
2020/10/02 | 4,426 | 4,440 | 4,270 | 4,285 | - | - | 1,267,100 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 4,613 | 4,624 | 4,437 | 4,448 | -165 | -3.6% | 1,609,700 |
2020/09/29 | 4,559 | 4,636 | 4,506 | 4,613 | +36 | +0.8% | 722,900 |
2020/09/28 | 4,578 | 4,590 | 4,494 | 4,577 | +47 | +1% | 1,075,700 |
2020/09/25 | 4,513 | 4,543 | 4,490 | 4,530 | +60 | +1.3% | 903,600 |
2020/09/24 | 4,466 | 4,485 | 4,444 | 4,470 | -13 | -0.3% | 633,200 |
2020/09/23 | 4,450 | 4,497 | 4,436 | 4,483 | +4 | +0.1% | 832,200 |
2020/09/18 | 4,450 | 4,488 | 4,445 | 4,479 | +3 | +0.1% | 891,400 |
2020/09/17 | 4,461 | 4,484 | 4,449 | 4,476 | +27 | +0.6% | 441,300 |
2020/09/16 | 4,490 | 4,493 | 4,440 | 4,449 | -70 | -1.5% | 847,200 |
2020/09/15 | 4,565 | 4,571 | 4,497 | 4,519 | -67 | -1.5% | 685,700 |
2020/09/14 | 4,564 | 4,610 | 4,547 | 4,586 | +47 | +1% | 533,900 |
2020/09/11 | 4,532 | 4,545 | 4,415 | 4,539 | +24 | +0.5% | 1,107,700 |
2020/09/10 | 4,498 | 4,519 | 4,479 | 4,515 | +62 | +1.4% | 716,800 |
2020/09/09 | 4,433 | 4,467 | 4,412 | 4,453 | -60 | -1.3% | 806,300 |
2020/09/08 | 4,477 | 4,513 | 4,444 | 4,513 | +59 | +1.3% | 578,100 |
2020/09/07 | 4,416 | 4,474 | 4,414 | 4,454 | +44 | +1% | 573,300 |
2020/09/04 | 4,517 | 4,520 | 4,398 | 4,410 | -200 | -4.3% | 1,435,700 |
2020/09/03 | 4,624 | 4,643 | 4,603 | 4,610 | -36 | -0.8% | 641,700 |
2020/09/02 | 4,671 | 4,690 | 4,624 | 4,646 | +22 | +0.5% | 411,500 |
2020/09/01 | 4,645 | 4,665 | 4,603 | 4,624 | -33 | -0.7% | 682,700 |
2020/08/31 | 4,650 | 4,699 | 4,625 | 4,657 | +37 | +0.8% | 648,100 |
2020/08/28 | 4,692 | 4,731 | 4,553 | 4,620 | -29 | -0.6% | 893,700 |
2020/08/27 | 4,700 | 4,720 | 4,640 | 4,649 | -11 | -0.2% | 368,900 |
2020/08/26 | 4,610 | 4,676 | 4,600 | 4,660 | +2 | ±0% | 645,000 |
2020/08/25 | 4,683 | 4,711 | 4,655 | 4,658 | +6 | +0.1% | 734,300 |
2020/08/24 | 4,651 | 4,671 | 4,614 | 4,652 | -21 | -0.4% | 430,300 |
2020/08/21 | 4,683 | 4,725 | 4,662 | 4,673 | +54 | +1.2% | 464,400 |
2020/08/20 | 4,679 | 4,685 | 4,610 | 4,619 | -116 | -2.4% | 870,500 |
2020/08/19 | 4,730 | 4,766 | 4,728 | 4,735 | +6 | +0.1% | 425,600 |
2020/08/18 | 4,728 | 4,756 | 4,703 | 4,729 | +2 | ±0% | 636,000 |
2020/08/17 | 4,777 | 4,784 | 4,727 | 4,727 | -59 | -1.2% | 434,900 |
2020/08/14 | 4,802 | 4,812 | 4,764 | 4,786 | +17 | +0.4% | 720,100 |
2020/08/13 | 4,796 | 4,799 | 4,738 | 4,769 | +29 | +0.6% | 1,000,200 |
2020/08/12 | 4,775 | 4,780 | 4,692 | 4,740 | -32 | -0.7% | 1,124,400 |
1151~
1200
件表示中 / 3561件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 677,200円 | +2.2% | +10.2% | 1.77% | 13.01倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 444,000円 | -1.1% | +75.3% | 4.50% | 30.42倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 322,300円 | +6.0% | +4.0% | 2.42% | 20.01倍 | 3.70倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 140,200円 | +0.9% | +380.2% | 5.56% | 19.31倍 | 1.66倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 250,600円 | +20.9% | +10.6% | 2.63% | 11.85倍 | 1.57倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム